Trial of Low-Dose Methotrexate and I 131 Tositumomab for Previously Untreated, Advanced-Stage, Follicular Lymphoma
Clinical trial NCT01389076 · TERMINATED
Trial details
- NCT number
- NCT01389076
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2014-02-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.